Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 05/29/2024, as announced by the company. The shares, valued at an aggregate market value of $1,015,876.80, were acquired by Bozic on 02/10/2024 through restricted stock vesting, a form of compensation from the issuer. This transaction follows a period where no securities were sold by Bozic in the past three months, as per the provided transaction history.

Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 05/29/2024, as announced by the company. The shares, valued at an aggregate market value of $1,015,876.80, were acquired by Bozic on 02/10/2024 through restricted stock vesting, a form of compensation from the issuer. This transaction follows a period where no securities were sold by Bozic in the past three months, as per the provided transaction history.